Source: PRSYNC

Press Release: Altravax : AltraVax Inc. - Product Pipeline Review - Market Research Report 2015

This report provides comprehensive information on the current therapeutic developmental pipeline of AltraVax Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michael Chambers's photo - Interim-CEO of Altravax

Interim-CEO

Michael Chambers

CEO Approval Rating

70/100

Read more